The clinically approved antiviral drug sofosbuvir inhibits Zika virus replicationCarolina Q. Sacramento, Thiago Moreno L. Souza, Natalia Fintelman‐Rodrigues et al.|Scientific Reports|2017Cited by 243
Emergence of the East-Central-South-African genotype of Chikungunya virus in Brazil and the city of Rio de Janeiro may have occurred years before surveillance detectionThiago Moreno L. Souza, Nischay Mishra, Yasmine Rangel Vieira et al.|Scientific Reports|2019Cited by 64
The clinically approved antiviral drug sofosbuvir impairs brazilian zika virus replicationCaroline Q. Sacramento, Thiago Moreno L. Souza, Gabrielle R. de Melo et al.|bioRxiv (Cold Spring Harbor Laboratory)|2016Cited by 25